Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Human Virology|April 25, 2000
Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoterP L Hermonat, A D Santin, J De Greve, et al.
Breast Cancer Research and Treatment|July 24, 2010
Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancerH Wildiers, C Fontaine, P Vuylsteke, et al.
Journal of Neuro-Oncology|September 28, 2010
Phase II study of sunitinib malate in patients with recurrent high-grade gliomaB Neyns, J Sadones, C Chaskis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Modulation of high-dose infusional fluorouracil by low-dose methotrexate in patients with advanced or metastatic colorectal cancer: final results of a randomized European Organization for Research and Treatment of Cancer StudyG Blijham, T Wagener, J Wils, et al.
Blood|May 1, 1995
Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib studyV D'Hondt, Y Humblet, T Guillaume, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Fotemustine in patients with advanced gastric cancer, a phase II trial from the EORTC-GITCCG (European Organization for Research and Treatment of Cancer, Gastrointestinal Tract Cancer Cooperative Group)P Rougier, C van Pottelsberghe, T Kok, et al.
Journal of Oncology|April 7, 2012
An observational study of the first experience with bevacizumab for the treatment of patients with recurrent high-grade glioma in two belgian university hospitalsM Huylebrouck, S Lv, J Duerinck, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphomaA M Seymour, E de Campos, N Thatcher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 2009
Stratified phase II trial of cetuximab in patients with recurrent high-grade gliomaB Neyns, J Sadones, E Joosens, et al.
British Journal of Cancer|July 5, 2001
Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trialC Focan, M Beauduin, E Salamon, et al.
Pageof 4